News
NIH inventors have developed a new strategy of using Interleukin 24 (IL-24) to target the whole T-helper 17 cells (Th17) lineage and thus achieve improved efficacy in therapy of Th17-relevant autoimmune diseases such as uveitis, multiple sclerosis, rheumatoid arthritis, and Crohn’s disease. The Th17
The Office of Intramural Research (OIR), has created a new Web site at http://oir.nih.gov that consolidates information on the numerous programs and activities that OIR oversees. A prominent feature of this site is what has been known for many years as the NIH "Intramural Sourcebook", a compendium
A new funding opportunity announcement (FOA) is available to move commercially viable diagnostic inventions from NIAID and NIDDK intramural research laboratories into the marketplace. This FOA solicits Small Business Innovation Research (SBIR) grant applications for projects that further develop and
The OTT is pleased to announce that the annual report for Fiscal Year 2013 is now available for downloading. Click the icon below to download and view the report.